CYTEK BIOSCIENCES, INC. Net Income (Loss) Attributable to Noncontrolling Interest
CYTEK BIOSCIENCES, INC. (CTKB) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-02-26
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2023-09-30 was $0.00.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-12-31 was $189.00K, a 626.92% increase year-over-year.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $0.00.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $0.00.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $0.00.
- CYTEK BIOSCIENCES, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$92.00K, a 453.85% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $189.00K derived: sum of 2 quarters · filed 2025-02-28 | $149.00K derived: sum of 3 quarters · filed 2025-02-28 | $253.00K derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $149.00K derived: sum of 2 quarters · filed 2025-02-28 | $253.00K derived: sum of 3 quarters · filed 2025-02-28 | -$92.00K 10-K · filed 2025-02-28 | $92.00K 10-K · filed 2023-03-01 | ||
| 2022-09-30 | -$40.00K 10-Q · filed 2023-11-14 | $40.00K 10-Q · filed 2022-11-09 | $64.00K derived: sum of 2 quarters · filed 2023-11-14 | -$281.00K 10-Q · filed 2023-11-14 | $281.00K 10-Q · filed 2022-11-09 | $227.00K derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-06-30 | $104.00K 10-Q · filed 2023-08-08 | $241.00K 10-Q · filed 2023-08-08 | $267.00K derived: sum of 3 quarters · filed 2024-03-13 | $267.00K derived: sum of 4 quarters · filed 2024-03-13 | |||
| 2022-03-31 | $137.00K 10-Q · filed 2023-05-09 | $163.00K derived: sum of 2 quarters · filed 2024-03-13 | $163.00K derived: sum of 3 quarters · filed 2024-03-13 | $163.00K derived: sum of 4 quarters · filed 2024-03-13 | |||
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $26.00K derived: sum of 2 quarters · filed 2024-03-13 | $26.00K derived: sum of 3 quarters · filed 2024-03-13 | $26.00K 10-K · filed 2024-03-13 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |